Ambu A/S (OTCMKTS:AMBBY) Shares Gap Up – Here’s What Happened

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) shares gapped up before the market opened on Wednesday. The stock had previously closed at $10.25, but opened at $11.00. Ambu A/S shares last traded at $11.00, with a volume of 200 shares traded.

Wall Street Analyst Weigh In

Separately, UBS Group lowered shares of Ambu A/S from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 15th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of “Hold”.

Ambu A/S Trading Up 7.6%

The company’s 50 day moving average price is $10.79 and its 200 day moving average price is $10.36. The company has a market cap of $2.58 billion, a price-to-earnings ratio of 36.67 and a beta of 0.93. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.69 and a current ratio of 2.77.

Ambu A/S (OTCMKTS:AMBBY) last announced its earnings results on Tuesday, August 25th. The company reported $0.09 earnings per share (EPS) for the quarter. Ambu A/S had a return on equity of 8.49% and a net margin of 8.18%.The firm had revenue of $255.12 million during the quarter.

Ambu A/S Company Profile

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. The company focuses on reducing the need to reprocess reusable equipment while supporting clinical procedures in areas such as endoscopy, anesthesia and patient monitoring.

Ambu’s product portfolio includes disposable endoscopes and related visualization systems, airway management products, anesthesia equipment and devices used for patient monitoring and diagnostics.